BMC Cancer

ISSN	1471-2407
ISSN-L	1471-2407
IUID	84d3762b48394373ba857dcf423042bf
Modified	2020-11-27T13:14:03.707Z
Created	2017-05-09T09:12:54.653Z

Year 2023

PubMed DOI Crossref

Public and patient involvement: a survey on knowledge, experience and opinions among researchers within a precision oncology European project.

Mosconi P, Colombo C, Paletta P, ..., Brunelli C, CEE_DART Consortium

BMC Cancer 23 (1) 814 [2023-08-30; online 2023-08-30]

Global Proteomics and Proteogenomics [Technology development]

PubMed DOI Crossref

Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer.

Kerzeli IK, Kostakis A, Türker P, ..., Lord M, Mangsbo SM

BMC Cancer 23 (1) 605 [2023-06-30; online 2023-06-30]

Affinity Proteomics Uppsala [Service]

PubMed DOI Crossref

Exposure to nonanoic acid alters small intestinal neuroendocrine tumor phenotype.

Almobarak B, Amlani V, Inge L, ..., Arvidsson Y, Elias E

BMC Cancer 23 (1) 267 [2023-03-23; online 2023-03-23]

Clinical Genomics Gothenburg [Service]

Year 2022

PubMed DOI Crossref

Characterization of surface markers on extracellular vesicles isolated from lymphatic exudate from patients with breast cancer.

Ekström K, Crescitelli R, Pétursson HI, ..., Lässer C, Olofsson Bagge R

BMC Cancer 22 (1) 50 [2022-01-10; online 2022-01-10]

Integrated Microscopy Technologies Gothenburg [Service]

Year 2021

PubMed DOI Crossref

SMAD4 haploinsufficiency in small intestinal neuroendocrine tumors.

Hofving T, Elias E, Rehammar A, ..., Nilsson O, Arvidsson Y

BMC Cancer 21 (1) 101 [2021-01-28; online 2021-01-28]

Integrated Microscopy Technologies Gothenburg [Service]

Year 2020

PubMed DOI Crossref

Comprehensive metabolomics analysis of prostate cancer tissue in relation to tumor aggressiveness and TMPRSS2-ERG fusion status.

Dudka I, Thysell E, Lundquist K, ..., Wikström P, Gröbner G

BMC Cancer 20 (1) 437 [2020-05-18; online 2020-05-18]

Swedish Metabolomics Centre (SMC) [Service] Swedish NMR Centre (SNC) [Collaborative]

Year 2019

PubMed DOI Crossref

Multiplex plasma protein profiling identifies novel markers to discriminate patients with adenocarcinoma of the lung.

Djureinovic D, Pontén V, Landelius P, ..., Micke P, Ståhle E

BMC Cancer 19 (1) 741 [2019-07-29; online 2019-07-29]

Affinity Proteomics Uppsala [Collaborative] Bioinformatics Support for Computational Resources [Service] Clinical Biomarkers [Service] PLA and Single Cell Proteomics [Collaborative]

PubMed DOI Crossref

A novel human in vitro papillomavirus type 16 positive tonsil cancer cell line with high sensitivity to radiation and cisplatin.

Forslund O, Sugiyama N, Wu C, ..., Wennerberg J, Ekblad L

BMC Cancer 19 (1) 265 [2019-03-25; online 2019-03-25]

NGI Uppsala (Uppsala Genome Center) [Service] National Genomics Infrastructure [Service]

Year 2018

PubMed DOI Crossref

Metabolic control of PPAR activity by aldehyde dehydrogenase regulates invasive cell behavior and predicts survival in hepatocellular and renal clear cell carcinoma.

Andrejeva D, Kugler JM, Nguyen HT, ..., Loya AC, Cohen SM

BMC Cancer 18 (1) 1180 [2018-11-28; online 2018-11-28]

Swedish NMR Centre (SNC) [Service]

Year 2017

PubMed DOI Crossref

Intra-tumor heterogeneity in breast cancer has limited impact on transcriptomic-based molecular profiling.

Karthik GM, Rantalainen M, Stålhammar G, ..., Bergh J, Hartman J

BMC Cancer 17 (1) 802 [2017-11-29; online 2017-11-29]

NGI Stockholm (Genomics Applications) [Service] NGI Stockholm (Genomics Production) [Service] National Genomics Infrastructure [Service]

PubMed DOI Crossref

Tartrate-resistant acid phosphatase (TRAP/ACP5) promotes metastasis-related properties via TGFβ2/TβR and CD44 in MDA-MB-231 breast cancer cells.

Reithmeier A, Panizza E, Krumpel M, ..., Ek-Rylander B, Andersson G

BMC Cancer 17 (1) 650 [2017-09-15; online 2017-09-15]

Clinical Proteomics Mass spectrometry [Service] Global Proteomics and Proteogenomics [Service]

PubMed DOI Crossref

Loss of DIP2C in RKO cells stimulates changes in DNA methylation and epithelial-mesenchymal transition.

Larsson C, Ali MA, Pandzic T, ..., He L, Sjöblom T

BMC Cancer 17 (1) 487 [2017-07-17; online 2017-07-17]

Bioinformatics Support for Computational Resources [Service] NGI Uppsala (SNP&SEQ Technology Platform) [Service] NGI Uppsala (Uppsala Genome Center) [Service] National Genomics Infrastructure [Service]

PubMed DOI Crossref

A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma.

Gremel G, Djureinovic D, Niinivirta M, ..., Stewart GD, Pontén F

BMC Cancer 17 (1) 9 [2017-01-04; online 2017-01-04]

Tissue Profiling [Technology development]

Year 2016

PubMed DOI Crossref

ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer.

Magnusson K, Gremel G, Rydén L, ..., Jirström K, Pontén F

BMC Cancer 16 (1) 904 [2016-11-18; online 2016-11-18]

Tissue Profiling [Technology development]

PubMed DOI Crossref

Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer.

Mattsson JS, Brunnström H, Jabs V, ..., Micke P, Svensson MA

BMC Cancer 16 (-) 603 [2016-08-05; online 2016-08-05]

Clinical Genomics Uppsala [Service] Tissue Profiling [Collaborative]

Year 2015

PubMed DOI Crossref

Microsatellite instability and mutations in BRAF and KRAS are significant predictors of disseminated disease in colon cancer.

Birgisson H, Edlund K, Wallin U, ..., Glimelius B, Sundström M

BMC Cancer 15 (-) 125 [2015-03-14; online 2015-03-14]

Array and Analysis Facility

PubMed DOI Crossref

Clonal distribution of BCR-ABL1 mutations and splice isoforms by single-molecule long-read RNA sequencing.

Cavelier L, Ameur A, Häggqvist S, ..., Olsson-Strömberg U, Hermanson M

BMC Cancer 15 (-) 45 [2015-02-12; online 2015-02-12]

Bioinformatics Support for Computational Resources [Service] Clinical Genomics Uppsala NGI Uppsala (Uppsala Genome Center) [Service] National Genomics Infrastructure [Service]

Year 2014

PubMed DOI Crossref

1p36 deletion is a marker for tumour dissemination in microsatellite stable stage II-III colon cancer.

Mayrhofer M, Kultima HG, Birgisson H, ..., Glimelius B, Isaksson A

BMC Cancer 14 (-) 872 [2014-11-24; online 2014-11-24]

Array and Analysis Facility

PubMed DOI Crossref

Tyrosine phosphorylation profiling via in situ proximity ligation assay.

Elfineh L, Classon C, Asplund A, ..., Kamali-Moghaddam M, Lind SB

BMC Cancer 14 (-) 435 [2014-06-13; online 2014-06-13]

Affinity Proteomics Uppsala [Technology development] PLA and Single Cell Proteomics

Year 2013

PubMed DOI Crossref

Age dependence of tumor genetics in unfavorable neuroblastoma: arrayCGH profiles of 34 consecutive cases, using a Swedish 25-year neuroblastoma cohort for validation.

Cetinkaya C, Martinsson T, Sandgren J, ..., Díaz de Ståhl T, Hedborg F

BMC Cancer 13 (-) 231 [2013-05-09; online 2013-05-09]

NGI Stockholm (Genomics Applications) NGI Stockholm (Genomics Production) National Genomics Infrastructure

PubMed DOI Crossref

Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer.

O Leary PC, Penny SA, Dolan RT, ..., Jirström K, Gallagher WM

BMC Cancer 13 (-) 175 [2013-04-02; online 2013-04-02]

Tissue Profiling

Year 2012

PubMed DOI Crossref

Loss-of-heterozygosity on chromosome 19q in early-stage serous ovarian cancer is associated with recurrent disease.

Skirnisdottir I, Mayrhofer M, Rydåker M, Akerud H, Isaksson A

BMC Cancer 12 (-) 407 [2012-09-12; online 2012-09-12]

Array and Analysis Facility

PubMed DOI Crossref

The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients.

Medrek C, Pontén F, Jirström K, Leandersson K

BMC Cancer 12 (-) 306 [2012-07-23; online 2012-07-23]

Tissue Profiling

Year 2011

PubMed DOI Crossref

Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma.

Carén H, Djos A, Nethander M, ..., Nilsson S, Martinsson T

BMC Cancer 11 (-) 66 [2011-02-11; online 2011-02-11]

NGI Uppsala (SNP&SEQ Technology Platform) National Genomics Infrastructure

Year 2010

PubMed DOI Crossref

Tumour-specific HMG-CoAR is an independent predictor of recurrence free survival in epithelial ovarian cancer.

Brennan DJ, Brändstedt J, Rexhepaj E, ..., O'Herlihy C, Jirstrom K

BMC Cancer 10 (-) 125 [2010-04-01; online 2010-04-01]

Tissue Profiling